Clinical Trials
11 trialsNCT03313804 2026-03-11
Priming Immunotherapy in Advanced Disease With Radiation
University of Kentucky
Phase 2 Completed
NCT05166239 2026-01-23
HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT
Peking University
Phase 2 Completed
NCT05348668 2026-01-07
Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer
Anhui Provincial Hospital
Phase 2 Completed
NCT05440916 2025-12-02
PRIMM
University Medical Centre Maribor
Phase 2 Completed
NCT04681131 2025-09-25
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC
BioAtla, Inc.
Phase 2 Completed
NCT05509699 2025-08-29
Surufatinib Plus Anti-PD-1/L1 as Maintenance Therapy in Extensive-Stage Small Cell Lung Cancer
Hutchmed
Phase 2 Completed
NCT03984357 2025-07-17
PLATINUM
Sun Yat-sen University
Phase 2 Completed
NCT04997382 2025-02-25
CLASSIC5
Hunan Province Tumor Hospital
Phase 2 Completed
NCT03989336 2024-07-15
A Study of the Pan-immunotherapy in Patients With Relapsed/Refractory Ovarian Cancer
Chinese PLA General Hospital
Phase 2 Completed
NCT03817736 2024-05-09
START-FIT
The University of Hong Kong
Phase 2 Completed
NCT03511391 2024-01-23
CHEERS
University Hospital, Ghent
Phase 2 Completed